|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61P 1/00 | |||
| A61P 5/00 | |||
| A61P 11/00 | |||
| A61P 13/00 | |||
| A61P 17/00 | |||
| A61P 21/00 | |||
| A61P 25/14 | |||
| A61P 27/00 | |||
| A61P 29/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 1778279 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05767945.8 |
| Date of filing the European patent application | 2005-08-03 | |
| (97) | Date of publication of the European application | 2007-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2005/003057 |
| Date | 2005-08-03 |
| (87) | Number | WO 2006/013370 |
| Date | 2006-02-09 |
| (30) | Number | Date | Country code |
| 0417367 | 2004-08-04 | GB | |
| 0421290 | 2004-09-24 | GB | |
| 0421288 | 2004-09-24 | GB | |
| 0423953 | 2004-10-28 | GB | |
| 0423950 | 2004-10-28 | GB |
| (72) |
PANJWANI, Naveed, GB
WEBB, Paul, GB
PICKETT, Andy, GB
|
| (73) |
Ipsen Biopharm Limited,
Ash Road, Wrexham Industrial Estate,, Wrexham LL13 9UF,
GB
|
| (54) | PHARMACEUTICAL COMPOSITION CONTAINING BOTULINUM NEUROTOXIN A2 |
| PHARMACEUTICAL COMPOSITION CONTAINING BOTULINUM NEUROTOXIN A2 |